GGrantIndex
Sort

172,184 grants matching inflammation

Cellular senescence, inflammation and neurotransmission in Alzheimer's disease

$774,630
Erin R Hascup · Southern Illinois University Sch Of Med · R01 · FY2020 · AG

Genomics and Pharmacogenomics of Symptoms in Asthma

$774,627
Kelan G Tantisira · University Of California, San Diego · R01 · FY2021 · HL

Role of pannexin-1 hemichannels in NeuroAIDS

$774,618
Eliseo A Eugenin · University Of Texas Med Br Galveston · R01 · FY2018 · NS

Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth

$774,614
Kristina M Adams Waldorf · University Of Washington · R01 · FY2022 · HD

EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center

$774,609
Stephanie A Christenson · University Of California, San Francisco · U01 · FY2024 · HG

SIV-induced Inflammation Causes Functional Impairment of the PNS

$774,598
Joseph L Mankowski · Johns Hopkins University · R01 · FY2016 · NS

Induction, fate and function of inflammatory fibroblasts

$774,585
Dean Sheppard · University Of California, San Francisco · R01 · FY2024 · HL

CD39-carrying extracellular vesicles regulate pulmonary thrombosis in Sickle Cell Disease

$774,566
Prithu Sundd · Versiti Blood Health, Inc. · R01 · FY2025 · HL

Mental Stress and Myocardial Ischemia after MI: Sex Differences, Mechanisms and Prognosis

$774,542
Viola Vaccarino Vaccarino · Emory University · R01 · FY2022 · HL

The Contribution of the Oral Microbiome to Alzheimer’s Disease Risk

$774,536
Irene Yang · Emory University · R01 · FY2024 · NS

Aging Intervention Program

$774,515
Rafael De Cabo · National Institute On Aging · ZIA · FY2015 · AG

MULTIPLE-SCLEROSIS: A CD40 LIGAND ANTAGONIST

$774,510
Dartmouth College · R01 · FY2001 · NS

LOX-1 as a protective countermeasure in response to lung infection

$774,500
Lee Quinton · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · HL

Immunotherapy of inflammation, autoimmune disease and cancer

$774,498
Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE

Administrative Core

$774,485
Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P30 · FY2024 · AG

Thioredoxin mimicry: novel treatment of toxicant-mediated inhalational lung injur

$774,459
Garry John Southan · Radikal Therapeutics, Inc. · U01 · FY2014 · ES

Perinatal Programming of Infant Stress Reactivity and the Atopic Phenotype

$774,438
Rosalind J Wright · Brigham And Women'S Hospital · R01 · FY2011 · HL

Use of Modified mRNA for the Treatment of Diabetic Foot Ulceration

$774,435
Aristidis Veves · Beth Israel Deaconess Medical Center · R01 · FY2024 · DK

Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis

$774,416
Rebecca M. Brotman · University Of Maryland Baltimore · R01 · FY2023 · AI

An autoimmune center of excellence for the study of IgG4-related disease

$774,410
Shiv Subramaniam Pillai · Massachusetts General Hospital · U19 · FY2024 · AI

Systems Biology of Diffusion Impairment in HIV

$774,369
Alison Morris · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · HL

Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy

$774,257
Matthew Joel Feinstein · Northwestern University At Chicago · R01 · FY2021 · HL

Biochemistry and Pathophysiology of Factor XI and Contact Activation

$774,201
David Gailani · Vanderbilt University Medical Center · R35 · FY2024 · HL

The Underlying Biology of Health Disparities

$774,192
Michele K Evans · National Institute On Aging · ZIA · FY2023 · AG

Cellular mediators of vascular inflammation in treated HIV-infection

$774,125
Nicholas T. Funderburg · Ohio State University · R01 · FY2016 · HL